XML 53 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net (loss) income $ (87,893) $ 475
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 11,604 14,162
Amortization of debt issuance costs 1,335 1,943
Amortization of prior hedge effectiveness 3,095 2,226
Stock-based compensation 86,725 9,890
Impairment of long-lived assets 872 555
Impairment of available-for-sale debt securities 0 4,818
Loss on debt extinguishment 7,955 0
Discontinuance of interest rate swaps and write-off of prior hedge effectiveness 8,688 0
Loss on sale of business 0 1,764
Deferred income taxes (7,218) (141)
Change in fair value of financial guarantee (150) (1,100)
Change in fair value of derivative instruments 392 169
Change in fair value of other equity security (1,031) 0
Unrealized foreign exchange loss 1,002 1,039
Other 4 11
Changes in operating assets and liabilities, net of effects of disposal of business:    
Accounts receivable (3,040) (2,997)
Prepaid expenses and other current assets (5,562) 374
Other assets (2,283) 1,102
Accounts payable 14,635 11,354
Accrued expenses and other liabilities 7,416 4,431
Income tax payable (368) 17
Deferred revenue 23,978 31,977
Net cash provided by operating activities 60,156 82,069
Cash flows from investing activities    
Purchase of property and equipment (8,500) (7,819)
Payment upon extinguishment of interest rate swaps (3,283) 0
Sale of business, net of cash sold 0 (1,194)
Net cash used in investing activities (11,783) (9,013)
Cash flows from financing activities    
Repayment of capital lease obligations (24) (24)
Payment of debt issuance costs (767) 0
Repayment of 2018 Term Loan (524,300) (4,012)
Proceeds from 2018 Revolving Facility 0 40,000
Repayment of 2018 Revolving Facility 0 (40,000)
Repayment of hybrid debt (1,332) (757)
Payment upon extinguishment of hybrid debt (9,774) 0
Payment of contingent consideration (1,049) 0
Payment of special dividends (115) (239)
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions 581,833 0
Proceeds from private placement, net of underwriting discounts and commissions 85,050 0
Payment of stock issuance costs (5,634) 0
Repurchases of common stock for tax withholding obligations (1,462) (3,459)
Proceeds from exercise of stock options, net of cash paid for employee tax withholding 412 113
Net cash provided by (used in) financing activities 122,838 (8,378)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent 23 (89)
Net increase in cash, cash equivalents and restricted cash equivalent 171,234 64,589
Cash, cash equivalents and restricted cash equivalent, at beginning of the period 139,470 74,180
Cash, cash equivalents and restricted cash equivalent, at end of the period 310,704 138,769
Reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets    
Cash and cash equivalents 310,704 113,769
Restricted cash equivalent 0 25,000
Total cash, cash equivalents, and restricted cash equivalent shown in the condensed consolidated statements of cash flows 310,704 138,769
Non-cash investing and financing activities    
Conversion of Series A redeemable convertible preferred stock into common stock in connection with initial public offering 70,906 0
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 486 1,282
Change in fair value of hedged interest rate swaps and interest rate cap (5,817) 49
Transfer of interest rate swaps derivative liability to hybrid debt $ 0 $ 12,345